UCLA Health Jonsson Comprehensive Cancer Center | Strategic Alliance Partners

January 18, 2012

The molecular basis behind the relatively high incidence of secondary skin cancers after patients received vemurafenib has been discovered.

November 21, 2011

If IKK kinase, a group of inhibitory proteins, activity is not regulated properly, tumors in the body have the ability to migrate and proliferate.

July 25, 2011

In patients with metastatic melanoma, the BRAF inhibitor vemurafenib led to high objective response rates and durable treatment responses.

May 25, 2011

The past decade has brought a significant increase in attention to the role that food and nutrients might play in fighting cancer.

May 18, 2011

A dendritic cell vaccine under development may increase median survival time in patients with glioblastoma

May 11, 2011

Plenty of children are afraid to go to the doctor. Dennis Slamon used to look forward to it.